ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

SKP Skyepharma

443.00
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Skyepharma LSE:SKP London Ordinary Share GB00B3BFNB64 ORD 100P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 443.00 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Skyepharma Share Discussion Threads

Showing 53426 to 53446 of 53550 messages
Chat Pages: 2142  2141  2140  2139  2138  2137  2136  2135  2134  2133  2132  2131  Older
DateSubjectAuthorDiscuss
16/3/2016
11:03
Aceuk, large shareholders always have a clause in these merger /takeovers that if a higher offer came in they have the right to walk away from the agreement.

SKP is now in play, i would be very surprised if others did not get involved here.

debbie_does_dallas_twice
16/3/2016
11:03
I doubt HBM's support is absolute. If a higher offer came in, they would presumably consider it.
frazboy
16/3/2016
11:01
Seems this has been rushed out to some extent, a falling VEC share price would look less and less attractive by the day.....
soundbuy
16/3/2016
10:59
I guess having the support of HBM limits the attraction to an outsider?

To an extent though the board is obliged to consider all proposals.....

soundbuy
16/3/2016
10:45
What I find a little surprising is the lack of stock activity in Vectura. It will be a 60:40 split approximately in favour of Vectura yet SKP trades are getting on for £6 million and VEC less than half a million and no significant movement either way as though the merger will have little impact on them, if any.
alexchry
16/3/2016
10:40
"The deal has been recommended by both boards and received support from HBM Healthcare Investments, which holds approximately 28.5 per cent of Skyepharma."

I guess having the support of HBM limits the attraction to an outsider?

aceuk
16/3/2016
10:04
....Agreed, I'd be looking across the pond
soundbuy
16/3/2016
09:58
SoundBuy,

...yep, Pacira would save themselves an opportunity costs fortune in licences and milestone payments and I'm sure Shire could absorb a little one...

stentorian
16/3/2016
09:56
Must admit I'm disappointed, with no debt and strong growth I was looking forward to a continuation of the gains of the last few years, not sure now.
It may make sense from a corporate view, but it seems like we've been shackled to a weaker partner, revenues are about half SKPs.
Will have to consider my options on this....

diesel
16/3/2016
09:51
Well, thanks to skp. A wonderful multi bagger, and well done to those intelligent and brave enough to buy near the lows. Today's news - strange tbh. Particularly given CEO grant was building a strong reputation, and is now stepping down. I suspect the combined group will deliver decent long term returns, but it again takes out the most optimistic near term scenario for skp.
wigwammer
16/3/2016
09:49
stentorian

reckon some will be factoring this in..........

soundbuy
16/3/2016
09:48
great results, showing that they have a firm base going forward, at last...

Think the merger is too early in SKP's cycle and premium too low...

a merger brings about uncertainty as to whether the merged group will work well together...

Now they have a firmer footing, I think they could do much better on their own...

sikhthetech
16/3/2016
09:45
...so now we know why they didn't announce the results at 7.00am. SKP is worth way more than 410.5p per share. Tantamount to financial rape. The management have sold us down the river. Takeover offers please.
stentorian
16/3/2016
09:09
'The United States as a priority' caught my eye in the merger announcement. I wonder if they are going to have another try with Flutiform.
alexchry
16/3/2016
09:06
Maybe - I think the "compelling" offer put on the table is much [edited @9:47] too cheap. Vectura are gaining a lot of upside without having enjoyed SKP shareholders years of pain, and therefor very [edited @9:47] cheaply.
aceuk
16/3/2016
09:00
Counter offer (from across the pond)?
soundbuy
16/3/2016
08:58
small premium, but first reaction is disappointing and would have provided better value on its own - quite comfortably beat consensus earnings forecasts for 2015. That said, I need to look at Vectura properly - some undoubted synergies.

Vectura on significantly higher PE rating, but much faster short term growth.

18bt
16/3/2016
08:57
Worth the wait, the performance is becoming predictable.
diesel
16/3/2016
08:54
Another surprise, still trying to work out whether it is a pleasant surprise or not but it is the end of my hopes of a big takeover.
alexchry
16/3/2016
08:50
Picked up a few weeks ago, results at first sight look stunning
gersemi
16/3/2016
08:48
...RNS out now
stentorian
Chat Pages: 2142  2141  2140  2139  2138  2137  2136  2135  2134  2133  2132  2131  Older

Your Recent History

Delayed Upgrade Clock